By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Archimedes Pharma 

250 South Oak Way
Green Park
Reading    RG2 6UG  United Kingdom
Phone: 44-0-118-931-5050 Fax: 44-0-118-931-5051


SEARCH JOBS


Industry
Pharmaceutical






Company News
Depomed, Inc. (DEPO) Announces Acquisition of Lazanda® (fentanyl) Nasal Spray From Archimedes Pharma 7/30/2013 7:55:11 AM
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT(R) Technology for Nefecon(R) (PL-56) Program 12/13/2011 10:13:24 AM
Archimedes Pharma Launches Lazanda(R) - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 10/17/2011 11:32:08 AM
FDA Approves Archimedes Pharma's Lazanda(R) - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7/1/2011 6:38:49 AM
Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management 10/12/2010 11:42:09 AM
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 10/4/2010 7:37:08 AM
EC Regulator Rubber-Stamps Archimedes Pharma’s Intranasal Fentanyl Spray for Cancer Pain 9/1/2010 6:24:22 AM
Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey; Archimedes Given Grant To Create Up to 75 New Jobs 8/23/2010 7:57:43 AM
Genetic Technologies Limited (GTG.AX) Announces Archimedes Pharma's BREVAGen(TM) Pharmacoeconomic Data Presented at American Society of Clinical Oncology 2010 in Chicago 6/8/2010 10:58:32 AM
Private UK Drug Firm Archimedes Pharma Raises US $100 Million; Former Enzon Pharmaceuticals, Inc. (ENZN) Head Appointed as CEO; US Commercial Operations to be Established 3/2/2010 6:57:09 AM
123
//-->